Exploring cancer metabolic reprogramming through molecular imaging / / topic editors, Franca Podo, Istituto Superiore di Sanit a, Italy, Zaver M. Bhujwalla, The Johns Hopkins University School of Medicine, USA, Egidio Iorio, Istituto Superiore di Sanit a, Italy.
The inclusion of oncogene-driven reprogramming of energy metabolism within the list of cancer hallmarks (Hanahan and Weinberg, Cell 2000, 2011) has provided major impetus to further investigate the existence of a much wider metabolic rewiring in cancer cells, which not only includes deregulated cell...
Saved in:
Superior document: | Frontiers Research Topics |
---|---|
TeilnehmendeR: | |
Year of Publication: | 2017 |
Language: | English |
Series: | Frontiers Research Topics
|
Physical Description: | 1 electronic resource (242 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993546359104498 |
---|---|
ctrlnum |
(CKB)4100000000883860 (oapen)https://directory.doabooks.org/handle/20.500.12854/47228 (EXLCZ)994100000000883860 |
collection |
bib_alma |
record_format |
marc |
spelling |
Exploring cancer metabolic reprogramming through molecular imaging / topic editors, Franca Podo, Istituto Superiore di Sanit a, Italy, Zaver M. Bhujwalla, The Johns Hopkins University School of Medicine, USA, Egidio Iorio, Istituto Superiore di Sanit a, Italy. Frontiers Media SA 2017 1 electronic resource (242 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Frontiers Research Topics The inclusion of oncogene-driven reprogramming of energy metabolism within the list of cancer hallmarks (Hanahan and Weinberg, Cell 2000, 2011) has provided major impetus to further investigate the existence of a much wider metabolic rewiring in cancer cells, which not only includes deregulated cellular bioenergetics, but also encompasses multiple links with a more comprehensive network of altered biochemical pathways. This network is currently held responsible for redirecting carbon and phosphorus fluxes through the biosynthesis of nucleotides, amino acids, lipids and phospholipids and for the production of second messengers essential to cancer cells growth, survival and invasiveness in the hostile tumor environment. The capability to develop such a concerted rewiring of biochemical pathways is a versatile tool adopted by cancer cells to counteract the host defense and eventually resist the attack of anticancer treatments. Integrated efforts elucidating key mechanisms underlying this complex cancer metabolic reprogramming have led to the identification of new signatures of malignancy that are providing a strong foundation for improving cancer diagnosis and monitoring tumor response to therapy using appropriate molecular imaging approaches. In particular, the recent evolution of positron emission tomography (PET), magnetic resonance spectroscopy (MRS), spectroscopic imaging (MRSI), functional MR imaging (fMRI) and optical imaging technologies, combined with complementary cellular imaging approaches, have created new ways to explore and monitor the effects of metabolic reprogramming in cancer at clinical and preclinical levels. Thus, the progress of high-tech engineering and molecular imaging technologies, combined with new generation genomic, proteomic and phosphoproteomic methods, can significantly improve the clinical effectiveness of image-based interventions in cancer and provide novel insights to design and validate new targeted therapies. The Frontiers in Oncology Research Topic “Exploring Cancer Metabolic Reprogramming Through Molecular Imaging” focusses on current achievements, challenges and needs in the application of molecular imaging methods to explore cancer metabolic reprogramming, and evaluate its potential impact on clinical decisions and patient outcome. A series of reviews and perspective articles, along with original research contributions on humans and on preclinical models have been concertedly included in the Topic to build an open forum on perspectives, present needs and future challenges of this cutting-edge research area. English Creative Commons Attribution 4.0 International. CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode Description based on online resource ; title from PDF title page (viewed on 07/12/2021) Unrestricted online access star cancer metabolic reprogramming metabolism molecular imaging Cancer Imaging. 2-88945-234-4 Bhujwalla, Zaver M., editor. Iorio, Egidio, editor. Podo, F. (Franca), editor. |
language |
English |
format |
eBook |
author2 |
Bhujwalla, Zaver M., Iorio, Egidio, Podo, F. |
author_facet |
Bhujwalla, Zaver M., Iorio, Egidio, Podo, F. |
author2_variant |
z m b zm zmb e i ei f p fp |
author2_fuller |
(Franca), |
author2_role |
TeilnehmendeR TeilnehmendeR TeilnehmendeR |
title |
Exploring cancer metabolic reprogramming through molecular imaging / |
spellingShingle |
Exploring cancer metabolic reprogramming through molecular imaging / Frontiers Research Topics |
title_full |
Exploring cancer metabolic reprogramming through molecular imaging / topic editors, Franca Podo, Istituto Superiore di Sanit a, Italy, Zaver M. Bhujwalla, The Johns Hopkins University School of Medicine, USA, Egidio Iorio, Istituto Superiore di Sanit a, Italy. |
title_fullStr |
Exploring cancer metabolic reprogramming through molecular imaging / topic editors, Franca Podo, Istituto Superiore di Sanit a, Italy, Zaver M. Bhujwalla, The Johns Hopkins University School of Medicine, USA, Egidio Iorio, Istituto Superiore di Sanit a, Italy. |
title_full_unstemmed |
Exploring cancer metabolic reprogramming through molecular imaging / topic editors, Franca Podo, Istituto Superiore di Sanit a, Italy, Zaver M. Bhujwalla, The Johns Hopkins University School of Medicine, USA, Egidio Iorio, Istituto Superiore di Sanit a, Italy. |
title_auth |
Exploring cancer metabolic reprogramming through molecular imaging / |
title_new |
Exploring cancer metabolic reprogramming through molecular imaging / |
title_sort |
exploring cancer metabolic reprogramming through molecular imaging / |
series |
Frontiers Research Topics |
series2 |
Frontiers Research Topics |
publisher |
Frontiers Media SA |
publishDate |
2017 |
physical |
1 electronic resource (242 p.) |
isbn |
2-88945-234-4 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC270 |
callnumber-sort |
RC 3270.3 D53 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.99/407548 |
dewey-sort |
3616.99 6407548 |
dewey-raw |
616.99/407548 |
dewey-search |
616.99/407548 |
work_keys_str_mv |
AT bhujwallazaverm exploringcancermetabolicreprogrammingthroughmolecularimaging AT iorioegidio exploringcancermetabolicreprogrammingthroughmolecularimaging AT podof exploringcancermetabolicreprogrammingthroughmolecularimaging |
status_str |
n |
ids_txt_mv |
(CKB)4100000000883860 (oapen)https://directory.doabooks.org/handle/20.500.12854/47228 (EXLCZ)994100000000883860 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
Frontiers Research Topics |
is_hierarchy_title |
Exploring cancer metabolic reprogramming through molecular imaging / |
container_title |
Frontiers Research Topics |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
_version_ |
1797653545476947968 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04182nam-a2200397z--4500</leader><controlfield tag="001">993546359104498</controlfield><controlfield tag="005">20240424230140.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2017 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000000883860</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/47228</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000000883860</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1="0" ind2="0"><subfield code="a">RC270.3.D53</subfield></datafield><datafield tag="082" ind1="0" ind2="0"><subfield code="a">616.99/407548</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Exploring cancer metabolic reprogramming through molecular imaging /</subfield><subfield code="c">topic editors, Franca Podo, Istituto Superiore di Sanit a, Italy, Zaver M. Bhujwalla, The Johns Hopkins University School of Medicine, USA, Egidio Iorio, Istituto Superiore di Sanit a, Italy.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (242 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The inclusion of oncogene-driven reprogramming of energy metabolism within the list of cancer hallmarks (Hanahan and Weinberg, Cell 2000, 2011) has provided major impetus to further investigate the existence of a much wider metabolic rewiring in cancer cells, which not only includes deregulated cellular bioenergetics, but also encompasses multiple links with a more comprehensive network of altered biochemical pathways. This network is currently held responsible for redirecting carbon and phosphorus fluxes through the biosynthesis of nucleotides, amino acids, lipids and phospholipids and for the production of second messengers essential to cancer cells growth, survival and invasiveness in the hostile tumor environment. The capability to develop such a concerted rewiring of biochemical pathways is a versatile tool adopted by cancer cells to counteract the host defense and eventually resist the attack of anticancer treatments. Integrated efforts elucidating key mechanisms underlying this complex cancer metabolic reprogramming have led to the identification of new signatures of malignancy that are providing a strong foundation for improving cancer diagnosis and monitoring tumor response to therapy using appropriate molecular imaging approaches. In particular, the recent evolution of positron emission tomography (PET), magnetic resonance spectroscopy (MRS), spectroscopic imaging (MRSI), functional MR imaging (fMRI) and optical imaging technologies, combined with complementary cellular imaging approaches, have created new ways to explore and monitor the effects of metabolic reprogramming in cancer at clinical and preclinical levels. Thus, the progress of high-tech engineering and molecular imaging technologies, combined with new generation genomic, proteomic and phosphoproteomic methods, can significantly improve the clinical effectiveness of image-based interventions in cancer and provide novel insights to design and validate new targeted therapies. The Frontiers in Oncology Research Topic “Exploring Cancer Metabolic Reprogramming Through Molecular Imaging” focusses on current achievements, challenges and needs in the application of molecular imaging methods to explore cancer metabolic reprogramming, and evaluate its potential impact on clinical decisions and patient outcome. A series of reviews and perspective articles, along with original research contributions on humans and on preclinical models have been concertedly included in the Topic to build an open forum on perspectives, present needs and future challenges of this cutting-edge research area.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="540" ind1=" " ind2=" "><subfield code="a">Creative Commons Attribution 4.0 International.</subfield><subfield code="f">CC BY 4.0</subfield><subfield code="u">https://creativecommons.org/licenses/by/4.0/legalcode</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on online resource ; title from PDF title page (viewed on 07/12/2021)</subfield></datafield><datafield tag="506" ind1="0" ind2=" "><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer metabolic reprogramming</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metabolism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular imaging</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Imaging.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88945-234-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bhujwalla, Zaver M.,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Iorio, Egidio,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Podo, F.</subfield><subfield code="q">(Franca),</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-04-26 03:07:47 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2017-11-11 16:18:22 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338220320004498&Force_direct=true</subfield><subfield code="Z">5338220320004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338220320004498</subfield></datafield></record></collection> |